The Latest Breaking News on Business

Intel must maintain control of Intel Foundry even in case it decides to spin it off into a separate private or public company.

Despite Ulta Beauty’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

SBA Communications has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines.

Intel revealed that the U.S. government subsidies require it to retain at least 50.1% ownership of Intel Foundry if separated into a private entity, and limit sales to a single shareholder to 35% if the unit becomes public, before running into "change-in-control" provisions.

Although Cincinnati Financial has outperformed relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

Despite STERIS’ underperformance relative to the broader market over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Despite TransDigm’s underperformance over the past year compared to the broader S&P 500 Index, Wall Street analysts remain strongly bullish about its prospects.

Food store employees grapple with fewer hours and inflation – and sound alarm at merger of two largest chains